Get In Touch

The growing demand within the global single-use bioreactors market can be attributed to advancements in molecular and cellular studies. The functionality and applications of these bioreactors span into multiple domains within medical research and analysis. Furthermore, the performance-efficiency of single-use bioreactors also creates value for the market players. In recent times, cellular studies, cell culture, and single-cell analysis have emerged as the catchphrases in the medical industry. In this scenario, the growth of the global single-use bioreactors market remains uncontested. The rate of growth within this market largely relies on ability of medical researchers to discover new uses and applications of the product. Cellular biology is an important area of application for single-use bioreactors.

Transparency Market Research (TMR), in this report preview, uncovers several factors responsible for the growth of the global single-use bioreactors market. Approval of single-use bioreactors by multiple research organisations has garnered the attention of the masses in recent times. Furthermore, use of multiple-layers in developing single-use bioreactors has helped in establishing the worth of these devices. These bioreactors supersede the performance of culture vessels made from stainless steel. TMR predicts that the global single-use bioreactors market would expand at a sturdy CAGR of 13.5% over the period between 2017 and 2026. Moreover, the total value of the global single-use bioreactors market is set to touch US$ 1.5 Bn by 2026-end.

global single use  bioreactors  market

Biotechnology Companies Transcend as Key End-User

The past decade has witnessed several advancements and notable developments in the field of medical research. Based on end-use, the global single-use bioreactors market can be segmented on the basis of biopharmaceutical company and biotechnology company. The stellar pace of advancements in microbiology has led biotechnology companies to emerge as key end-users. On the basis of molecule type, the global single-use bioreactors market can be segmented into vaccines, monoclonal antibodies, stem cells, gene-modified cells, and other molecules.

Culturing of artificial cells holds tremendous relevance in the domain of medical research. Single-use bioreactors offer a custom environment for the growth and development of such cells. Successful analysis and study of these cells have been the basis for developing multiple lines of treatment. Moreover, mammalian cells are also studied under controlled environments in single-use bioreactors. It is safe to predict that the global single-use bioreactors market would grow by leaps and bounds in the years to follow. The relevance of single-use bioreactors in study of various cell types forms the basis for market growth.

North America to Witness Uptick in Demand

There is little contention about the presence of growth-oriented research institutes across several regional pockets. On the basis of regions, the global single-use bioreactors market can be segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Owing to advancements in medical research, the market in North America shall tread along a revenue-oriented path.

The growing relevance of molecular biology has garnered the attention of the medical industry. Besides, DNA sequencing is another key area that necessitates the study of cellular, molecular, and DNA structures. The aforementioned factors are expected to drive sales across the global single-use bioreactors market. Moreover, notable developments in genetic modification have paved way for market maturity and expansion, Study of genetic samples is an important application of single-use bioreactors. In addition to this, biological research has become an integral part of the medical industry. With increasing investments in medical research, the revenue index of the global single-use bioreactors market is poised to improve.

Some of the notable players operating in the global single-use bioreactors market are Solida Biotech, Sartorius Stedim Biotech, Merck Millipore, GE Healthcare, Distek, PBS Biotech, Celltainer Biotech, and Danaher.

Global Single-Use Bioreactors Market to Expand as New Applications of Bioreactors Emerge in the Pharma Sector

Use of single-use bioreactors across the domain of pharmaceutical manufacturing has created new opportunities for market growth and expansion. Over the course of the next decade, the pharma industry is slated to attract new revenues from research entities and organizations. This can be attributed to the tall claims and plans proposed by the pharmaceutical industry. The development of new treatment lines for a range of diseases has also necessitated the use of single-use bioreactors. The superiority of single-use bioreactors with other traditional bioreactors has given an impetus to the growth of the global market. Several new vendors are slated to emerge in the global single-use bioreactors market as new pharma lines show primary success.

  • The use of bioreactors spans into a multitude of domains within pharmaceutical manufacturing. Some of these uses include vaccine development, excipient research, clinical trials, and other relevant domains. Henceforth, the global single-use bioreactors market holds tremendous opportunities for growth and expansion in recent times. The outbreak of the novel coronavirus has unravelled new opportunities for growth across the global single-use bioreactors market. The need to develop an effective vaccine has become a pressing need across the entire world. This has caused an uptick in the use of several types of bioreactors. The premium quality and performance of single-use bioreactors has given a thrust to market expansion.
  • The demand for cleaning and sterilization after the use of bioreactors has been a matter of concern for the chemical industry. In this context, the availability of single-use bioreactors can be a boon for the vendors operating in this market. Moreover, several entities in the chemical industry have approved of the benefits of single-use reactors over conventional ones. Considering the aforementioned dynamics, it is safe to state that the global single-use bioreactors market would attract fresh revenues in the times to follow.

Global Single-Use Bioreactors Market: Overview

Single-use bioreactors are being used on a large scale in today’s biotechnology manufacturing facility. Moreover, there has also been a significant growth in the use of single-use bioreactors in the pharmaceutical industry across the globe. The use is increasing as they provide immense flexibility to the pharmaceutical companies. Single-use bioreactor helps in mitigating the risk of cross-contamination, especially during the production of multi-drugs at pharmaceutical manufacturing units. This is helping the pharmaceutical companies save time and also leads to the significant cost saving. Due to these factors, there has been a high preference for single-use bioreactors.

The single-use bioreactor is expected to play a crucial role in the pharmaceutical industry, resulting in the rapid development of a new variety of drugs that will help in treating various diseases that are currently untreatable and becoming more prevalent. Manufacturers are focusing on introducing high-power single-use bioreactors and the control systems are also being improved to help in multiple unit operations. New systems are also being designed specifically for microbial fermentation.

Global Single-Use Bioreactors Market: Research Methodology

The report on the global single-use bioreactor market offers an overview of the present market state and also provides insights on the future growth of the market and key segments for the forecast period between 2017 and 2026. The report also offers an in-depth analysis of the market dynamics including trends, drivers, challenges, opportunities, and regulatory framework of the global market. These market dynamics are expected to have an influence on the future growth prospects of the market.

The report offers both quantitative and qualitative data analysis based on primary as well as secondary research. The report also provides an analysis of various elements in the market based on Porter’s five forces analysis, SWOT analysis, and analysis on market attractiveness. Various tools are used for validating gathered data and insights that are expected to significantly influence the business decision making process.

The report also talks about the key microeconomic and macroeconomic factors that are likely to have an impact on the overall development of the market during the forecast period between 2017 and 2026. All the data provided by the report can help the companies in formulating the growth strategies for earning better returns in the global single-use bioreactors market.  

Global Single-Use Bioreactors Market: Market Segmentation

The global single-use bioreactors market is segmented on the basis of product type, end user, cells type, molecule type, and region. On the basis of product type, the market is segmented into single use bioreactor systems, media bags, filtration assemblies, and other products. On the basis of end user, the segment includes biopharmaceutical companies, biotechnology companies and other end users. By cells type, the market is segmented into mammalian cells, bacterial cells, yeast cells and other cells. By molecule type, the market is segmented into monoclonal antibodies (MABS), vaccines, stem cells, gene-modified cells and other molecules.  

Region-wise, the global single use bioreactor market is segmented into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). The report provides forecast, revenue share, and market size for each segment as well as for each region for 2017 to 2026. The data is provided in the form of US$ Mn and CAGR in percent form.

Global Single-Use Bioreactors Market: Competitive Landscape

The report provides detailed analysis of some of the leading market players in the global single-use bioreactors market such as Sartorius Stedim Biotech, Merck Millipore, GE Healthcare, Danaher, Thermo Fisher Scientific, Parker Hannifin, Applikon Biotechnology, Eppendorf, Cesco Bioengineering, Cellexus, Celltainer Biotech, PBS Biotech, Distek, Solida Biotech, and Pierre Guerin. All of the leading players in the market are evaluated on parameters including product portfolio, company overview, strategies, financial overview, and latest developments.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Single Use Bioreactors Market

Buy Now